4ANDRADE CR JR, CLEMENTE EL, GOMES MDE B. Body adiposity and its influence on clinical and metabolic parameters of patients with type 1 diabetes[J]. Arq Bras Endocrinol Metabol, 2004, 48(6):885-889.
5Gan MJ, Albanese-O' Neill A, Haller MJ. Type Idiabetes: current concepts in epidemiology, pathophysiology, clinical care, and research[J].Curr Probl Pediatr Adolesc Health Care, 2012, 42(10): 269-291.
二级参考文献30
1[1]Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993, 42:359-362
2[2]Juneja R, Palmer JP. Type 1.5 Diabetes: myth or reality?Autoimmunity, 1997, 29:65-83
3[3]World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications:report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland:World Health Organization, 1999
4[6]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000, 85:76-80
5[7]Tuomi T, Carlsson A, Li H, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes, 1999, 48:150-157
6[8]Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24:683-689
7[9]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve beta cells in slowly progressive insulindependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130
8[10]Dubuquoy L, Bourdon C, Peuchmaur M, et al. Peroxisome proliferator activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease. Gastroenterol Clin Biol, 2000, 24:719-724
9[11]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse:implications for human type 1 diabetes. Diabetes Metab Res Rev, 2002, 18:114-117
10Bonifacio E, Lampasona V, Genovese S, et al. Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin dependent diabetes-related 37/40Kautoantigen and a target of islet-cell antibodies [J]. J Immunol 1995,155:5419-5
